How does the hypothalamus regulate the autonomic nervous system?
The hypothalamus exerts supreme control over the autonomic nervous system (ANS). Its distinct regions produce opposing effects on the body:
- Rostral (anterior) region: Mediates parasympathetic (trophotropic) activity. Its stimulation promotes rest and recovery. Blood pressure (BP) and heart rate (HR) decrease, and tidal volume drops. Gastrointestinal motility, salivation, and bladder contraction increase. Pupils constrict and metabolism slows down.
- Caudal (posterior) region: Triggers sympathetic (ergotropic) activity. Prepares the body for stress and physical exertion. BP, HR, and respiratory rate increase. Blood flow to skeletal muscles and lungs is enhanced, while gastrointestinal capillary beds constrict. Motility is suppressed, urine is retained, and blood levels of glucose and adrenaline rise. Pupils and palpebral fissures dilate.
Neuroendocrine Regulation and Hypothalamic Nuclei
The hypothalamus contains up to 50 pairs of nuclei and is functionally connected to the pituitary gland via two main secretory systems:
- Magnocellular nuclei (anterior hypothalamus): Comprises the supraoptic (above the optic chiasm) and paraventricular (in the lateral wall of the third ventricle) nuclei. They are formed by large neurosecretory cells that synthesize the peptide hormones antidiuretic hormone (ADH, vasopressin) and oxytocin. These hormones are transported via axons to the posterior pituitary (neurohypophysis), where they are released into the bloodstream.
- Parvocellular nuclei (medial hypothalamus): Located in the region of the tuber cinereum, such as the arcuate nucleus. They produce hypophysiotropic hormones that control the anterior pituitary (adenohypophysis). Neurosecretory products are released into the hypophyseal portal system. These hormones include releasing hormones (liberins) (stimulate the synthesis and secretion of adenohypophyseal hormones, e.g., corticotropin-releasing hormone and thyrotropin-releasing hormone) and inhibiting hormones (statins) (suppress the synthesis and secretion of tropic hormones, e.g., somatostatin and prolactin-inhibiting factor — dopamine).
Centers of Biological Motivations and Emotions
The hypothalamus is the center of primary biological drives such as hunger, thirst, and sexual desire, and it houses thermoregulatory centers as well as sleep-wake centers.
- Regulation of feeding behavior: The sensation of hunger is triggered by falling plasma glucose levels and gastric muscle contractions during stomach emptying. The hypothalamus produces appetite stimulants: GABA, dopamine, $\beta$-endorphin, and enkephalins. Appetite inhibitors that promote satiety include serotonin, norepinephrine, cholecystokinin, and somatostatin.
- Emotions and the heart: Stimulation of negative emotion-generating centers in the hypothalamus causes profound cardiac disturbances, such as arrhythmias and extrasystoles. Stimulation of positive emotion-generating centers causes similar, though less pronounced, changes. If negative center stimulation is followed immediately by positive center stimulation, cardiac arrhythmias are largely prevented.
- Memory: The hypothalamic pacemaker plays a critical role in memory engram formation. Learning and engram consolidation occur through the interaction of motivational states and reinforcing factors. Complete erasure of a memory engram is observed only when hypothalamic pacemaker activity is suppressed.
Physiological Properties of Neurons
Key physiological features of hypothalamic neurons include:
- Absence of a blood-brain barrier: Allows direct contact between neurons and circulating blood.
- High sensitivity to humoral factors: Neurons respond to changes in oxygen and carbon dioxide partial pressures, ambient pH, sodium and potassium ion concentrations, and catecholamine levels.
- Presence of glucosensors: Located within the ventrobasal and lateral nuclei.
Clinical Significance
Knowledge of hypothalamic hormones is essential in pharmacology. For example, octreotide is a synthesized stable octapeptide analog of somatostatin. It suppresses growth hormone secretion, as well as exocrine pancreatic secretion and gastrointestinal peptide release. It is used in endocrinology to treat acromegaly and gigantism, in gastroenterology for acute pancreatitis, and to manage bleeding esophageal varices.